2:15 – 3:15 pm Saturday, October 30

Treating Smarter, Not Harder: Abandoning Intensification and Replacing with Immunotherapy for Patients with Down Syndrome and B-ALL (C234)

coglogoChildren with Down syndrome (DS) have a striking predisposition for developing acute leukemia, with a 40-fold increased risk of developing acute lymphoblastic leukemia (ALL) compared to non-DS patients (Wadhwa et al, 2017). Approximately 3% of children with ALL have DS, and these children have inferior outcomes and higher rates of treatment-related mortality (TRM) and are at greater risk of relapse (Buitenkamp et al., 2014).

3:30 – 4:30 pm Friday, October 29

Hot Topics in Pediatric Oncology: Updates from the Children’s Oncology Group (C217)

coglogoImprovements in patient care occur when new research findings are moved into practice. The average length of time for this translation, however, is 17 years. Within the past 3 years, the Children’s Oncology Group (COG) has produced 248 publications (about 83 per year).

5:00 – 6:00 pm Thursday, October 28

Lighting the Way in COG with MATCH: Targeted Therapies in Pediatric CNS Tumors (C211)

coglogoPediatric MATCH (Molecular Analysis for Therapy Choice) is a joint effort between the National Cancer Institute (NCI) and Children’s Oncology Group (COG) matching targeted therapies to specific tumor genomic sequencing in patients with relapsed or refractory solid tumors, non-Hodgkin lymphomas, brain tumors, and histiocytic disorders.


Pediatric Chemotherapy and Biotherapy Instructor Course (002)

The APHON Pediatric Chemotherapy and Biotherapy Instructor Course is designed for any nurse who has completed the provider course and meets the qualifications to be trained to teach the course. This course provides general instruction in adult education, guidance in the planning of lectures based on the APHON program content, and instruction in administering the provider exam. Upon successful completion, nurses return to their institutions as recognized APHON Pediatric Chemotherapy and Biotherapy Instructors who are able to provide ongoing instruction and education to other registered nurses.


Practical Workings of a Pediatric and Adolescent Fertility Preservation Program, from Consults to Care Models (003)

In recent years, there has been increased emphasis on fertility preservation (FP) in pediatric hematology/oncology centers. The growing population of cancer patients and patients receiving hematopoietic cell transplants (HCTs) for nonmalignant diseases (e.g., sickle cell disease) has resulted in more patients expressing interest in FP information and interventions at Children’s Healthcare of Atlanta (CHOA).

James Ludemann, BSN RN OCN CPHON®

Megan Pruett, MSN CPNP

$110 for members
$140 for non-members
CNE Hours
11:30 am – 12:30 pm Friday, October 29

Post-Transplant Lymphoproliferative Disorder: Managing the Complexities of the Pediatric Solid Organ Transplant Patient (212)

Posttransplant lymphoproliferative disorders (PTLDs) are recognized as one of the most devastating complications following solid organ transplantation. PTLD encompasses a wide range of clinical conditions—from benign lymphoproliferation to widespread malignancies with aggressive behavior. The development of PTLDs is driven by Epstein-Barr virus in the vast majority of pediatric PTLD cases.

Subscribe to this RSS feed